Medicine and Dentistry
Acute Coronary Syndrome
42%
Acute Heart Infarction
100%
Adverse Outcome
14%
Angina pectoris
14%
Blood Clot Lysis
14%
Clinical Trial
28%
Coronary Angiography
14%
Coronary Artery Disease
14%
Dalteparin Sodium
14%
Diseases
14%
Glycoprotein IIb/IIIa Inhibitors
14%
Health Care Cost
14%
Heart Muscle Revascularization
100%
Infarction
14%
Ischemia
14%
Myocardial Infarction
42%
Non ST Segment Elevation Myocardial Infarction
100%
Percutaneous Coronary Intervention
14%
Q Wave
14%
Revascularization
14%
ST Elevation
100%
Target Lesion
14%
Tirofiban
14%
Unstable Angina Pectoris
100%
Veterans Affairs
14%
Keyphrases
Acute Coronary Syndrome
37%
Adverse Outcomes
12%
Aggressive Strategy
12%
Angina
12%
Atherosclerotic Disease
12%
Clinical High Risk
12%
Clinical Trials
25%
Conservative Approach
25%
Coronary Arteriography
12%
Coronary Artery Disease
12%
Coronary Revascularization
100%
Coronary Stent
12%
Death Rate
12%
Event Reduction
12%
Fragmin
12%
Glycoprotein IIb/IIIa Inhibitors
12%
High Risk
12%
Infarction
12%
Intermediate Risk
25%
Invasive Approach
25%
Invasive Strategy
37%
Ischemia
12%
Lipid-lowering Therapy
12%
Myocardial Infarction
25%
Percutaneous Coronary Intervention
12%
Plaque Instability
12%
Q Wave
12%
Rehospitalization
12%
Revascularization
12%
ST-elevation Myocardial Infarction (STEMI)
100%
Stable Angina
87%
Target Lesion
12%
Therapy Costs
12%
Thrombolysis in Myocardial Infarction
12%
Veterans Affairs
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
42%
Acute Heart Infarction
100%
Adverse Outcome
14%
Clinical Trial
28%
Coronary Artery Disease
14%
Dalteparin
14%
Diseases
14%
Fibrinogen Receptor
14%
Heart Infarction
42%
Infarction
14%
Ischemia
14%
Non ST Segment Elevation Myocardial Infarction
100%
Tirofiban
14%
Unstable Angina Pectoris
100%